InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Schwartz Brian, 董事. Director active across 3 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 6 disclosures have been published. Activity tracked since 15 June 2021. The latest transaction was filed on 29 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Schwartz Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
12,500 股0Common StockSEC:0001104659-24-008862:0
21,219 股0Common StockSEC:0001104659-23-077650:0
30,919 股@ US$0.679100.0% 占其流量Common StockSEC:0001140361-22-023308:0
15,822 股0Common StockSEC:0001104659-22-071895:0
2,374 股0Common StockSEC:0001104659-21-082597:0
2,847 股Common StockSEC:0001019695-16-000057:0
6 条申报中的 6 条
About Schwartz Brian
Brian Schwartz is a Board Member at Cyclacel Pharmaceuticals, Inc. and INFINITY PHARMACEUTICALS, INC. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the pharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.
